Palo Alto Investors LP Insmed Inc Transaction History

Palo Alto Investors LP

$727 Million
Q3 2024

A detailed history of Palo Alto Investors LP transactions in Insmed Inc stock. As of the latest transaction made, Palo Alto Investors LP holds 1,940,993 shares of INSM stock, worth $127 Million. This represents 19.49% of its overall portfolio holdings.

Number of Shares

1,940,993

Previous 2,138,963 9.26%

Holding current value

$127 Million

Previous $143 Million 1.13%

% of portfolio

19.49%

Previous 18.14%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$62.0 - $79.01 $12.3 Million - $15.6 Million	-197,970 Reduced 9.26%	1,940,993 $142 Million
Q2 2024 Aug 14, 2024	SELL	$22.0 - $69.71 $50.3 Million - $159 Million	-2,284,406 Reduced 51.64%	2,138,963 $143 Million
Q1 2024 May 15, 2024	SELL	$25.72 - $29.94 $28 Million - $32.6 Million	-1,088,352 Reduced 19.75%	4,423,369 $120 Million
Q4 2023 Feb 14, 2024	SELL	$23.42 - $31.74 $8.85 Million - $12 Million	-377,770 Reduced 6.41%	5,511,721 $171 Million
Q1 2023 May 15, 2023	BUY	$16.26 - $21.73 $295,932 - $395,486	18,200 Added 0.31%	5,889,491 $100 Million
Q4 2022 Feb 14, 2023	BUY	$16.98 - $23.15 $524,563 - $715,172	30,893 Added 0.53%	5,871,291 $117 Million
Q2 2022 Aug 15, 2022	SELL	$17.07 - $25.71 $698,180 - $1.05 Million	-40,901 Reduced 0.7%	5,840,398 $115 Million
Q1 2022 May 16, 2022	SELL	$20.42 - $28.13 $2.95 Million - $4.06 Million	-144,407 Reduced 2.4%	5,881,299 $138 Million
Q4 2021 Feb 14, 2022	BUY	$25.89 - $33.45 $170,874 - $220,770	6,600 Added 0.11%	6,025,706 $164 Million
Q2 2021 Aug 16, 2021	BUY	$24.17 - $36.01 $4.7 Million - $7.01 Million	194,599 Added 3.34%	6,019,106 $171 Million
Q1 2021 May 17, 2021	SELL	$32.28 - $44.3 $9.09 Million - $12.5 Million	-281,473 Reduced 4.61%	5,824,507 $198 Million
Q4 2020 Feb 16, 2021	BUY	$31.45 - $40.54 $2.3 Million - $2.96 Million	73,024 Added 1.21%	6,105,980 $203 Million
Q3 2020 Nov 16, 2020	BUY	$26.0 - $34.5 $797,342 - $1.06 Million	30,667 Added 0.51%	6,032,956 $194 Million
Q2 2020 Aug 14, 2020	SELL	$14.11 - $29.42 $752,542 - $1.57 Million	-53,334 Reduced 0.88%	6,002,289 $165 Million
Q1 2020 May 15, 2020	SELL	$13.63 - $33.98 $10.8 Million - $27 Million	-793,137 Reduced 11.58%	6,055,623 $97.1 Million
Q4 2019 Feb 14, 2020	SELL	$16.12 - $24.98 $6.3 Million - $9.76 Million	-390,889 Reduced 5.4%	6,848,760 $164 Million
Q3 2019 Nov 14, 2019	SELL	$15.49 - $25.78 $10.1 Million - $16.8 Million	-651,268 Reduced 8.25%	7,239,649 $128 Million
Q2 2019 Aug 14, 2019	BUY	$23.0 - $32.19 $5.46 Million - $7.64 Million	237,300 Added 3.1%	7,890,917 $202 Million
Q4 2018 Feb 14, 2019	BUY	$11.6 - $18.7 $3.44 Million - $5.54 Million	296,334 Added 4.03%	7,653,617 $100 Million
Q3 2018 Nov 14, 2018	BUY	$18.95 - $28.08 $2.29 Million - $3.39 Million	120,700 Added 1.67%	7,357,283 $149 Million
Q2 2018 Aug 14, 2018	BUY	$20.0 - $29.72 $1.54 Million - $2.29 Million	76,993 Added 1.08%	7,236,583 $171 Million
Q1 2018 May 15, 2018	BUY	$21.69 - $32.99 $16.4 Million - $24.9 Million	755,004 Added 11.79%	7,159,590 $161 Million
Q4 2017 Feb 14, 2018	BUY	$26.43 - $31.78 $6.15 Million - $7.4 Million	232,770 Added 3.77%	6,404,586 $200 Million
Q3 2017 Nov 14, 2017	BUY	$11.61 - $31.21 $71.7 Million - $193 Million	6,171,816	6,171,816 $193 Million

Others Institutions Holding INSM

# of Institutions

467

Shares Held

180M

Call Options Held

2.27M

Put Options Held

3.33M

View Full List

About INSMED Inc

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $8.84B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

More about INSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Palo Alto Investors LP, based on Form 13F filings with the SEC.

News

Stay updated on Palo Alto Investors LP with notifications on news.

Account

Palo Alto Investors LP Insmed Inc Transaction History